Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
EDQM
0
USP
0
JP
0
Others
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
API
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
1. 1092977-61-1
2. 2-((3-butoxyphenethyl)amino)-n,n-dimethylacetamide
3. Evenamide [inn]
4. Nw-3509
5. On5s6n53js
6. Mfcd28502433
7. 2-((2-(3-butoxyphenyl)ethyl)amino)-n,n-dimethylacetamide
8. Acetamide, 2-((2-(3-butoxyphenyl)ethyl)amino)-n,n-dimethyl-
9. 2-[(3-butoxyphenethyl)amino]-n,n-dimethylacetamide
10. Unii-on5s6n53js
11. Evenamid
12. Evenamide [who-dd]
13. Schembl3025285
14. Chembl3678076
15. Bdbm161090
16. Dtxsid101032897
17. Sb18910
18. Ac-35786
19. As-48527
20. Hy-17612
21. Sy244487
22. Cs-0014697
23. F50592
24. Q21098995
25. 2-[2-(3-butoxyphenyl)ethylamino]-n,n-dimethylacetamide
26. Us9051240, 2-[2-(3-butoxyphenyl)-ethylamino]-n,n-dimethylacetamide
| Molecular Weight | 278.39 g/mol |
|---|---|
| Molecular Formula | C16H26N2O2 |
| XLogP3 | 2.5 |
| Hydrogen Bond Donor Count | 1 |
| Hydrogen Bond Acceptor Count | 3 |
| Rotatable Bond Count | 9 |
| Exact Mass | 278.199428076 g/mol |
| Monoisotopic Mass | 278.199428076 g/mol |
| Topological Polar Surface Area | 41.6 Ų |
| Heavy Atom Count | 20 |
| Formal Charge | 0 |
| Complexity | 269 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
Drugs in Development
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Digital Content
NEWS #PharmaBuzz
ABOUT THIS PAGE
64
PharmaCompass offers a list of Evenamide API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Evenamide manufacturer or Evenamide supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Evenamide manufacturer or Evenamide supplier.
PharmaCompass also assists you with knowing the Evenamide API Price utilized in the formulation of products. Evenamide API Price is not always fixed or binding as the Evenamide Price is obtained through a variety of data sources. The Evenamide Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A NW-3509 manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of NW-3509, including repackagers and relabelers. The FDA regulates NW-3509 manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. NW-3509 API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A NW-3509 supplier is an individual or a company that provides NW-3509 active pharmaceutical ingredient (API) or NW-3509 finished formulations upon request. The NW-3509 suppliers may include NW-3509 API manufacturers, exporters, distributors and traders.
NW-3509 Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of NW-3509 GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right NW-3509 GMP manufacturer or NW-3509 GMP API supplier for your needs.
A NW-3509 CoA (Certificate of Analysis) is a formal document that attests to NW-3509's compliance with NW-3509 specifications and serves as a tool for batch-level quality control.
NW-3509 CoA mostly includes findings from lab analyses of a specific batch. For each NW-3509 CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
NW-3509 may be tested according to a variety of international standards, such as European Pharmacopoeia (NW-3509 EP), NW-3509 JP (Japanese Pharmacopeia) and the US Pharmacopoeia (NW-3509 USP).
